Lilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bnLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bnLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bn
Next issueIssue 16 · Tue 29 Sep 

Companies

University of Chieti-Pescara

Universita' Degli Studi G. D'Annunzio Di Chieti

HQ
IT
Status
active
Listing
Private
Current stage
academic sponsor

euclinicaltrials.euregistryverified 2026-09-08

Notes on the record

University; not a company. Sponsor of record on CTIS for A011, sponsor type Educational Institution. Legal name kept in the CTIS spelling so the asset row resolves. No ClinicalTrials.gov record found for the trial on 2026-09-08.

Assets

Registered trials

Deals

This company is not a party to any row in data/deals.csv.

In the briefing

1 issue tagged CHIETI.